Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis

ClinicalTrials.gov ID: NCT01243983

Public ClinicalTrials.gov record NCT01243983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Masked, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects With Active Noninfectious Uveitis Involving the Intermediate and/or Posterior Segments of the Eye

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the safety and efficacy of voclosporin as therapy in subjects with active noninfectious uveitis involving the intermediate and/or posterior segments of the eye (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis).

Study identification

NCT ID
NCT01243983
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lux Biosciences, Inc.
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Jan 9, 2013

2011 – 2012

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Not listed Peoria Arizona 85381
Not listed Phoenix Arizona 85014
Not listed Little Rock Arkansas 72205
Not listed Beverly Hills California 90211
Not listed Mountain View California 94040
Not listed Sacramento California 95819
Not listed Santa Ana California 92705
Not listed Torrance California 90503
Not listed Indianapolis Indiana 46290
Not listed Ellsworth Maine 04605
Not listed Baltimore Maryland 21287
Not listed Cambridge Massachusetts 02142
Not listed Newark New Jersey 07103
Not listed Belmont North Carolina 28012
Not listed Winston-Salem North Carolina 27157
Not listed Cleveland Ohio 44122
Not listed Cleveland Ohio 44195
Not listed Dublin Ohio 43016
Not listed Middleburg Heights Ohio 44130
Not listed Ashland Oregon 97520
Not listed Philadelphia Pennsylvania 19107
Not listed Ladson South Carolina 29456
Not listed Arlington Texas 76012
Not listed Dallas Texas 75231
Not listed Houston Texas 77030
Not listed San Antonio Texas 78240
Not listed Norfolk Virginia 23502
Not listed Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01243983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2013 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01243983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →